ArticleCurrent addiction reports2014
Impact of Cannabis Use on the Development of Psychotic Disorders.
Article in Current addiction reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed, 3 syntheses or guidelines pooled it, 128 citations in OpenAlex.
- Patterns of brain function associated with cannabis cue-reactivity in regular cannabis users: a systematic review of fMRI studies.Psychopharmacology · 2021Pooled it
- The Behavioral Sequelae of Cannabis Use in Healthy People: A Systematic Review.Frontiers in psychiatry · 2021Pooled it
- A review of Indian research on co-occurring cannabis use disorders& psychiatric disorders.The Indian journal of medical research · 2017Pooled it
- An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease.The journal of pain · 2016Trial
- White matter signatures of addiction diverge across opioids, cannabis and nicotine and predict impulsive choice in cannabis dependence.Translational psychiatry · 2026Article
- Medical workup in pediatric first psychotic presentation: real-world diagnostic utility in a large tertiary cohort.European child & adolescent psychiatry · 2026Article
- Synergistic pathways to psychosis: understanding developmental risk and resilience factors.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026Review
- Investigating Cannabis-Use Among Students Attending High Schools Within the Cherokee Nation Reservation 2017 and 2019.Journal of community health · 2024Article
- Psychotic Cannabis Withdrawal: A Clinical Case.Cureus · 2022Article
- Medical cannabis: Critical points for clinical applicationBiomedica : revista del Instituto Nacional de Salud · 2022Article
- Safety and Efficacy of Medical Cannabis in Autism Spectrum Disorder Compared with Commonly Used Medications.Cannabis and cannabinoid research · 2022Observational
- Variations of cannabis-related adverse mental health and addiction outcomes across adolescence and adulthood: A scoping review.Frontiers in psychiatry · 2022Article
- Form and content of Jamaican cannabis edibles.Journal of cannabis research · 2021Article
- Review
- Adolescent Gender Identity, Sexual Orientation, and Cannabis Use: Potential Mediations by Internalizing Disorder Risk.Health education & behavior : the official publication of the Society for Public Health Education · 2021Article
- Prospects for the Use of Cannabinoids in Psychiatric Disorders.Frontiers in psychiatry · 2021Review
- Psychotic experiences from preadolescence to adolescence: when should we be worried about adolescent risk behaviors?European child & adolescent psychiatry · 2020Article
- Cannabis use among U.S. adolescents in the era of marijuana legalization: a review of changing use patterns, comorbidity, and health correlates.International review of psychiatry (Abingdon, England) · 2020Review
- Cannabis Surveillance With Twitter Data: Emerging Topics and Social Bots.American journal of public health · 2020Article
- Astrocytic Mechanisms Involving Kynurenic Acid Control ΔMolecular neurobiology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
Abstract
The link between cannabis use and psychosis comprises three distinct relationships: acute psychosis associated with cannabis intoxication, acute psychosis that lasts beyond the period of acute intoxication, and persistent psychosis not time-locked to exposure. Experimental studies reveal that cannabis, tetrahydrocannabinol (THC) and synthetic cannabinoids reliably produce transient positive, negative, and cognitive symptoms in healthy volunteers. Case-studies indicate that cannabinoids can induce acute psychosis which lasts beyond the period of acute intoxication but resolves within a month. Exposure to cannabis in adolescence is associated with a risk for later psychotic disorder in adulthood; this association is consistent, temporally related, shows a dose-response, and is biologically plausible. However, cannabis is neither necessary nor sufficient to cause a persistent psychotic disorder. More likely it is a component cause that interacts with other factors to result in psychosis. The link between cannabis and psychosis is moderated by age at onset of cannabis use, childhood abuse and genetic vulnerability. While more research is needed to better characterize the relationship between cannabinoid use and the onset and persistence of psychosis, clinicians should be mindful of the potential risk of psychosis especially in vulnerable populations, including adolescents and those with a psychosis diathesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.